The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
David D. Waters
Division of Cardiology
San Francisco General Hospital
and the Department of Medicine
University of California
USA. Electronic address:
Name/email consistency: high
- Utility of biomarkers and imaging in the development of drugs for the treatment of coronary atherosclerosis. Waters, D.D. Can. J. Cardiol (2012)
- Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. Waters, D.D., Ho, J.E., DeMicco, D.A., Breazna, A., Arsenault, B.J., Wun, C.C., Kastelein, J.J., Colhoun, H., Barter, P. J. Am. Coll. Cardiol. (2011)
- Exploring new indications for statins beyond atherosclerosis: Successes and setbacks. Waters, D.D. J. Cardiol (2010)
- Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Waters, D.D., Brotons, C., Chiang, C.W., Ferrières, J., Foody, J., Jukema, J.W., Santos, R.D., Verdejo, J., Messig, M., McPherson, R., Seung, K.B., Tarasenko, L. Circulation (2009)
- Clinical insights from the Treating to New Targets trial. Waters, D.D. Prog. Cardiovasc. Dis (2009)
- Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation. Waters, D.D., Ku, I. J. Am. Coll. Cardiol. (2009)
- What the statin trials have taught us. Waters, D.D. Am. J. Cardiol. (2006)
- Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study. Waters, D.D., LaRosa, J.C., Barter, P., Fruchart, J.C., Gotto, A.M., Carter, R., Breazna, A., Kastelein, J.J., Grundy, S.M. J. Am. Coll. Cardiol. (2006)
- Safety of high-dose atorvastatin therapy. Waters, D.D. Am. J. Cardiol. (2005)
- Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?. Waters, D.D., Guyton, J.R., Herrington, D.M., McGowan, M.P., Wenger, N.K., Shear, C. Am. J. Cardiol. (2004)
- Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Hsue, P.Y., Giri, K., Erickson, S., MacGregor, J.S., Younes, N., Shergill, A., Waters, D.D. Circulation (2004)
- Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Waters, D.D., Schwartz, G.G., Olsson, A.G., Zeiher, A., Oliver, M.F., Ganz, P., Ezekowitz, M., Chaitman, B.R., Leslie, S.J., Stern, T. Circulation (2002)
- Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. Waters, D.D., Alderman, E.L., Hsia, J., Howard, B.V., Cobb, F.R., Rogers, W.J., Ouyang, P., Thompson, P., Tardif, J.C., Higginson, L., Bittner, V., Steffes, M., Gordon, D.J., Proschan, M., Younes, N., Verter, J.I. JAMA (2002)
- What do the statin trials tell us?. Waters, D.D. Clin. Cardiol (2001)
- Are we aggressive enough in lowering cholesterol?. Waters, D.D. Am. J. Cardiol. (2001)
- What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?. Waters, D.D., Hsue, P.Y. Am. J. Cardiol. (2001)
- Early pharmacologic intervention and plaque stability in acute coronary syndromes. Waters, D.D. Am. J. Cardiol. (2001)
- The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?. Waters, D., Schwartz, G.G., Olsson, A.G. Curr. Control. Trials. Cardiovasc. Med (2001)
- Medical therapy versus revascularization: the atorvastatin versus revascularization treatment AVERT trial. Waters, D.D. Can. J. Cardiol (2000)
